Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: Results of a preliminary study

Psychopharmacology

Volumn 197, Issue 1, 2008, Pages 95-105

  McClernon, F Joseph ^a   Kollins, Scott H ^a   Lutz, Avery M ^a   Fitzgerald, David P ^a   Murray, Desiree W ^a   Redman, Christina ^a   Rose, Jed E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Attention deficit hyperactivity disorder; Nicotine dependence; Smoking; Withdrawal

Indexed keywords

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; COGNITION; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MOOD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPONSE TIME; SMOKING; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; TOBACCO DEPENDENCE; VISUAL INFORMATION; WITHDRAWAL SYNDROME;

ADULT; AFFECT; AROUSAL; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; CROSS-SECTIONAL STUDIES; CUES; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MOTIVATION; NEUROPSYCHOLOGICAL TESTS; NICOTINE; PATTERN RECOGNITION, VISUAL; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 40949089335     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-1009-3     Document Type: Article

References (66)

1. APA (2000) Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, 4th edn
2. Barkley RA, Murphy KR, O'Connell T, Connor DF (2005) Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder. J Safety Res 36:121-131
3. Bekker EM, Bocker KB, Van Hunsel F, van den Berg MC, Kenemans JL (2005) Acute effects of nicotine on attention and response inhibition. Pharmacol Biochem Behav 82:539-548
4. Boonstra AM, Kooij JJ, Oosterlaan J, Sergeant JA, Buitelaar JK (2005) Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD? J Clin Exp Neuropsychol 27:278-298
5. Castellanos FX, Elia J, Kruesi MJ, Marsh WL, Gulotta CS, Potter WZ, Ritchie GF, Hamburger SD, Rapoport JL (1996) Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder. Neuropsychopharmacology 14:125-137
6. Congdon E, Lesch KP, Canli T (2007) Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity. Am J Med Genet B Neuropsychiatr Genet (in press)
7. Conners CK (1994) The Conners Continuous Performance Test. Multi-Health Systems, Toronto, Canada
8. Conners C, Erhardt D, Sparrow E, staff M (1998) The Conners Adult ADHD Rating Scale (CAARS). Multi-Health Systems, Toronto, Canada
9. Epstein JN, Johnson D, Conners CK (2000) Conners' Adult ADHD Diagnostic Interview for DSM-IV. Multi-Health Systems, North Tonawanda, NY
10. First MB, Gibbon M, Williams JBW, Spitzer RL (1997) SCID Screen Patient Questionnaire - Extended Version. Multi-Health Systems, North Tonawanda, NY
11. Gilbert D, McClernon J, Rabinovich N, Sugai C, Plath L, Asgaard G, Zuo Y, Huggenvik J, Botros N (2004) Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits. Nicotine Tob Res 6:249-267
12. Gilbert DG, McClernon FJ, Rabinovich NE, Plath LC, Masson CL, Anderson AE, Sly KF (2002) Mood disturbance fails to resolve across 31 days of cigarette abstinence in women. J Consult Clin Psychol 70:142-152
13. Gimpel GA, Collett BR, Veeder MA, Gifford JA, Sneddon P, Bushman B, Hughes K, Odell JD (2005) Effects of stimulant medication on cognitive performance of children with ADHD. Clin Pediatr (Phila) 44:405-411
14. Grace AA (2001) Psychostimulant actions on dopamine and limbic system function: Relevance to the pathophysiology and treatment of ADHD, in Stimulant drugs and ADHD: Basic and clinical neuroscience. Oxford University Press, Oxford University Press
15. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA (2004) Nicotine Dependence and Psychiatric Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61:1107-1115
16. Hahn B, Stolerman IP (2002) Nicotine-induced attentional enhancement in rats: effects of chronic exposure to nicotine. Neuropsychopharmacology 27:712-722
17. Hatsukami D, Fletcher L, Morgan S, Keenan R, Amble P (1989) The effects of varying cigarette deprivation duration on cognitive and performance tasks. J Subst Abuse 1:407-416
18. Heishman SJ (1998) What aspects of human performance are truly enhanced by nicotine? Addiction 93:317-320
19. Heishman SJ, Taylor RC, Henningfield JE (1994) Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharmacol 2:345-395
20. Hendricks PS, Ditre JW, Drobes DJ, Brandon TH (2006) The early time course of smoking withdrawal effects. Psychopharmacology (Berl) 187:385-396
21. Hildebrand BE, Nomikos GG, Hertel P, Schilstrom B, Svensson TH (1998) Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Brain Res 779:214-225
22. Hood J, Baird G, Rankin PM, Isaacs E (2005) Immediate effects of methylphenidate on cognitive attention skills of children with attention-deficit-hyperactivity disorder. Dev Med Child Neurol 47:408-414
23. Hughes JR (2007) Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 9:315-327
24. Humfleet GL, Prochaska JJ, Mengis M, Cullen J, Munoz R, Reus V, Hall SM (2005) Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res 7:453-460
25. Jacob P 3rd, Wilson M, Benowitz NL (1981) Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr 222:61-70
26. Kalman D, Morissette SB, George TP (2005) Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14:106-123
27. Koelega HS (1993) Stimulant drugs and vigilance performance: a review. Psychopharmacology (Berl) 111:1-16
28. Lambert NM, Hartsough CS (1998) Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 31:533-544
29. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH (2000) Smoking and mental illness: a population-based prevalence study. JAMA 284:2606-2610
30. Levin ED, Conners CK, Silva D, Canu W, March J (2001) Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol 9:83-90
31. Levin ED, Conners CK, Silva D, Hinton SC, Meck WH, March J, Rose JE (1998) Transdermal nicotine effects on attention. Psychopharmacology (Berl) 140:135-141
32. Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH, Rose JE, March J (1996) Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 123:55-63
33. Levin ED, McClernon FJ, Rezvani AH (2006) Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 184:523-539
34. Lorr M, McNair D (1984) Manual: profile of mood statesEducational and Industrial Testing ServiceEducational and Industrial Testing Service
35. Losier BJ, McGrath PJ, Klein RM (1996) Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychol Psychiatry 37:971-987
36. Marczinski CA, Fillmore MT (2003) Dissociative antagonistic effects of caffeine on alcohol-induced impairment of behavioral control. Exp Clin Psychopharmacol 11:228-236
37. McClernon FJ, Rose JE (2005) Mecamylamine moderates cue-induced emotional responses in smokers. Addict Behav 30:741-753
38. Mendrek A, Monterosso J, Simon SL, Jarvik M, Brody A, Olmstead R, Domier CP, Cohen MS, Ernst M, London ED (2006) Working memory in cigarette smokers: Comparison to non-smokers and effects of abstinence. Addict Behav 31: 833-844
39. Milberger S, Biederman J, Faraone SV, Chen L, Jones J (1997a) ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 36:37-44
40. Milberger S, Biederman J, Faraone SV, Wilens T, Chu MP (1997b) Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. Am J of Addiction 6:318-329
41. Molina BS, Pelham WE Jr. (2003) Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychology 112:497-507
42. Pomerleau CS, Downey KK, Snedecor SM, Mehringer AM, Marks JL, Pomerleau OF (2003) Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology. Addict Behav 28:1149-1157
43. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS (1995) Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 7:373-378
44. Potter AS, Newhouse PA (2004) Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 176:182-194
45. Powell J, Dawkins L, Davis RE (2002) Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model. Biol Psychiatry 51:151-163
46. Powell JH, Pickering AD, Dawkins L, West R, Powell JF (2004) Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation. Addict Behav 29:1407-1426
47. Rahman S, Zhang J, Engleman EA, Corrigall WA (2004) Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study. Neuroscience 129:415-424
48. Rezvani AH, Levin ED (2001) Cognitive effects of nicotine. Biol Psychiatry 49:258-267
49. Riccio CA, Waldrop JJ, Reynolds CR, Lowe P (2001) Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 13:326-335
50. Rohde P, Kahler CW, Lewinsohn PM, Brown RA (2004) Psychiatric disorders, familial factors, and cigarette smoking: II. Associations with progression to daily smoking. Nicotine Tob Res 6: 119-132
51. Rose J, Behm F (2004) Effects of low nicotine content cigarettes on smoke intake. Nicotine Tob Res 6:309-319
52. Rose JE, Levin ED, Behm FM, Adivi C, Schur C (1990) Transdermal nicotine facilitates smoking cessation. Clin Pharmacol Ther 47:323-330
53. Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62:649-659
54. Schweitzer JB, Lee DO, Hanford RB, Zink CF, Ely TD, Tagamets MA, Hoffman JM, Grafton ST, Kilts CD (2004) Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity. Biol Psychiatry 56:597-606
55. Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology (Berl) 50:35-39
56. Solanto MV (1998) Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94:127-152
57. Turner DC, Blackwell AD, Dowson JH, McLean A, Sahakian BJ (2005) Neurocognitive effects of methylphenidate in adult attention-deficit/ hyperactivity disorder. Psychopharmacology (Berl) 178:286-295
58. Volkow ND, Wang GJ, Fowler JS, Ding YS (2005) Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1410-1415
59. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitzemann R, Pappas N (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155:1325-1331
60. Warburton DM, Mancuso G (1998) Evaluation of the information processing and mood effects of a transdermal nicotine patch. Psychopharmacology (Berl) 135:305-310
61. Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54:1063-1070
62. Weinberger AH, Sacco KA, Creeden CL, Vessicchio JC, Jatlow PI, George TP (2007) Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia. Schizophr Res 91:217-225
63. Wesnes K, Warburton DM (1983) Effects of smoking on rapid information processing performance. Neuropsychobiology 9:223-229
64. Wilens TE, Biederman J, Spencer TJ, Bostic J, Prince J, Monuteaux MC, Soriano J, Fine C, Abrams A, Rater M, Polisner D (1999) A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry 156:1931-1937
65. Xian H, Scherrer JF, Madden PA, Lyons MJ, Tsuang M, True WR, Eisen SA (2005) Latent class typology of nicotine withdrawal: genetic contributions and association with failed smoking cessation and psychiatric disorders. Psychol Med 35:409-419
66. Zack M, Belsito L, Scher R, Eissenberg T, Corrigall WA (2001) Effects of abstinence and smoking on information processing in adolescent smokers. Psychopharmacology (Berl) 153:249-257